Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 14 Apr 2023 for Jasper Therapeutics, Inc., €9,372. Read the official filing
Filing timeline
BuySaleAnna Louise French
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Anna Louise French: trading record in brief
Anna Louise French is a declared insider of Jasper Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 12 October 2022 and 14 April 2023, the trades on record add up to 2 filings.
On the market, this insider has only sold: 1 sale, €9,372 in total. Other entries cover 1 share grant. 2023 to date brings no purchases and 1 sale.
The latest filing, published on 14 April 2023, reports an open-market sale of €9,372 in Jasper Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anna Louise French
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
7,000 shares@ US$1.48100.0% of flowVoting Common StockSEC:0001213900-23-029901:0
30,750 shares0Voting Common StockSEC:0001213900-22-063934:0
2 of 2 declarations
